Piper Sandler Lowers Humacyte (NASDAQ:HUMA) Price Target to $10.00
Humacyte (NASDAQ:HUMA – Get Rating) had its target price decreased by equities researchers at Piper Sandler from $17.00 to $10.00 in a research note issued on Tuesday, The Fly reports. Piper Sandler’s price target suggests a potential upside of 37.55% from the stock’s previous close. Separately, Zacks Investment Research upgraded Humacyte from a “hold” rating […]